T45.60
Poisoning by, adverse effect of and underdosing of unspecified fibrinolysis-affecting drugs
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T45.60 pertains to complications arising from the use of drugs that influence the process of fibrinolysis, which is the body's mechanism for breaking down blood clots. This code covers cases of poisoning, adverse effects, and unintended underdosing of these medications. While fibrinolytic drugs are essential in treating specific medical conditions, such as acute heart attacks or strokes caused by blood clots, improper use or adverse reactions can lead to serious health issues. Recognizing and understanding these complications is important for healthcare providers and patients alike.
Causes & Symptoms
Clinical Causes: Incorrect administration or dosing of fibrinolytic drugs Sensitivity or allergic reactions to fibrinolytic agents Drug interactions that enhance toxicity Use of fibrinolytic drugs in contraindicated situations Accidental ingestion or overdose
Key Symptoms: Unusual bleeding or bruising Extended bleeding from cuts or wounds Signs of internal bleeding, such as abdominal pain or blood in stool or urine Allergic reactions, including rash, swelling, or difficulty breathing Symptoms of overdose, including dizziness, weakness, or extreme fatigue
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough medical history and review of medication usage. Blood tests, such as coagulation profiles, may be used to assess bleeding risks. Additional tests might include imaging studies to identify internal bleeding or injury. Healthcare providers consider patient history, medication records, and clinical presentation to determine the cause of adverse effects related to fibrinolytic drugs.
Treatment Protocols: Management typically includes stopping the offending medication and providing supportive care tailored to the patient's symptoms. In cases of significant bleeding, reversal agents such as antifibrinolytics may be administered under medical supervision. Monitoring and managing potential complications, including bleeding or allergic reactions, are crucial. Treatment also involves addressing any underlying conditions that necessitated fibrinolytic therapy in the first place.
Clinical Advice & FAQs
Billing Guidance
Is T45.60 a billable ICD-10 code?
Yes, T45.60 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.60?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of unspecified fibrinolysis-affecting drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference